发明名称 COMPOUNDS THAT MODULATE PPAR ACTIVITY AND METHODS FOR THEIR PREPARATION.
摘要 THIS INVENTION DISCLOSES COMPOUNDS THAT ALTER PPAR ACTIVITY. THE INVENTION ALSO DISCLOSES PHARMACEUTICALLY ACCEPTABLE SALTS OF THE COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS COMPRISING THE COMPOUNDS OR THEIR SALTS, AND METHODS OF USING THEM AS THERAPEUTIC AGENTS FOR TREATING OR PREVENTING HYPERLIPIDEMIA, HYPERCHOLESTEREMIA, OBESITY, EATING DISORDERS, HYPERGLYCEMIA, ATHEROSCLEROSIS, HYPERTRIGLYCERIDEMIA, HYPERINSULINEMIA AND DIABETES IN A MAMMAL AS WELL AS METHODS OF SUPRESSING APPETITE AND MODULATING LEPTIN LEVELS IN A MAMMAL. THE PRESENT INVENTION ALSO DISCLOSES METHODS FOR MAKING THE DISCLOSED COMPOUNDS.
申请公布号 MY134199(A) 申请公布日期 2007.11.30
申请号 MY2003PI01235 申请日期 2003.04.02
申请人 WARNER-LAMBERT COMPANY LLC 发明人 GARY FREDERICK FILZEN;BHARAT KALIDAS TRIVEDI;ANDREW GEORGE GEYER;PAUL CHARLES UNANGST;LARRY DON BRATTON;BRUCE JEFFREY AUERBACH
分类号 A61K31/19;A61K31/192;A61K31/353;A61K31/381;A61K31/404;A61K31/4168;A61K31/4178;A61K31/42;A61K31/422;A61K31/4245;A61K31/44;A61K31/4402;A61K31/445;A61K31/4525;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P35/00;A61P43/00;C07C27/02;C07C51/00;C07C51/09;C07C59/135;C07C59/70;C07C59/72;C07C315/04;C07C317/22;C07C319/20;C07C323/19;C07C323/20;C07C323/21;C07D209/10;C07D211/14;C07D211/18;C07D213/20;C07D213/30;C07D213/32;C07D231/12;C07D233/68;C07D235/18;C07D261/08;C07D271/06;C07D271/10;C07D295/092;C07D307/79;C07D311/58;C07D333/54;C07D405/06;C07D405/10;C07D405/12;C07D413/04;C07D413/12;C07D521/00 主分类号 A61K31/19
代理机构 代理人
主权项
地址